represented at the meeting by Sharansky, director general Moshe Vigdor and the head of the financial department, Yaron Neudorfer. Outgoing El Al CEO Haim Romano and former Israel Air Force chief Eliezer Shkedy, who has been named his replacement, represented the airline.

El Al said the deputy directors of both parties would meet in an effort to reach a mutually acceptable deal.

Meanwhile, the Jewish Agency signed a NIS 2 million contract with El Al competitor Israir to fly immigrants from Moscow, Berlin, Rome, Milan, Basel and Nice to Israel.

The Jewish Agency also recently signed a NIS 4.1 million agreement with a third Israeli airline, Arkia, to fly in immigrants from Paris, Kiev, Tbilisi and Munich. Until that deal, which was reported this week, the larger ailrine had a monopolyUsing in situ modification to enhance organic fouling resistance and rejection of pharmaceutical and personal care products in a thin-film composite nanofiltration membrane.
A commercially available nanofiltration membrane, NF90, was modified using an in situ concentration polarization-enhanced radical graft polymerization method to improve the organic fouling resistance as well as the removal of pharmaceutical and personal care products (PPCPs), including ibuprofen (IBU), carbamazepine, sulfadiazine, sulfamethoxazole, sulfamethazine, and triclosan (TRI). 3-Sulfopropyl methacrylate potassium salt (SPM) and 2-hydroxyethyl methacrylate (HEMA) were used in various dosages for surface modification, and the extent of membrane modifications was quantified based on the degree of grafting. The modified NF90 exhibited a 15-40% lower flux during humic acid (HA) fouling and 25% greater NaCl rejection compared with the virgin membrane. PPCP rejection in the modified NF90